Bridging the valley: From bench to early phase
Tracks
Track 2
Thursday, October 31, 2024 |
2:20 PM - 3:05 PM |
Room 109 |
Overview
Sponsored by: CYTIVA
Details
Join our panellists as we discuss the leap across the valley to early phase human clinical trials. Each of the panel are ready to share their journeys over the hurdles of scaling, showcasing their dedication to pushing the boundaries of innovation.
Embarking on human early phase trials brings a blend of awe and excitement. At this pivotal moment, the focus sharpens on guaranteeing safety, refining dosages, and closely monitoring for potential side effects. This stage also underscores the necessity for increased drug substance production, spotlighting the essential task of scaling up operations with precision and care.
Scaling up involves more than just boosting numbers; it is an opportunity to delve into the heart of the process, fine-tuning every aspect from reaction conditions to the use of equipment and purification methods.
Speaker
A/Prof. Helen Benham
Executive Director - Translation
Translational Research Institute
Panellist
Dr. Pat James
Group Leader, Regulated Biomanufacturing
CSIRO